Study #2022-0600
A study of ABC008 in subjects with T-cell large granular lymphocytic leukemia (T-LGLL)
MD Anderson Study Status
Not Accepting
Treatment Agent
ABC008
Description
An open label, ascending dose study for adult subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
T-cell Large Granular Lymphocytic Leukemia
Study phase:
Physician name:
Tapan Kadia
Department:
Leukemia
For general questions about clinical trials:
1-888-448-0874
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.